YOLFTbeta
30

Fujian Cosunter Pharmaceutical Co Ltd

300436 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

73.75CNY-2.56 (-3.35%)

Price History

Full chart

Market Stats

Previous Close76.31
Open79.36
Day Range73.56 – 79.50
52-Week Range79.00 – 149.00
Volume3.62M
Market Cap14.06B
P/E (TTM)0.00
Forward P/E0.00
EPS-1.38
Dividend Yield0.00%
Beta1.18
50-Day Avg90.74
200-Day Avg102.14

About

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men's health, and other fields. It also provides technical services such as drug development, including the development and quality research of active pharmaceutical ingredients (APIs) and formulation processes. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yan Ru Hu
  • Employees715
  • HeadquartersBuilding 16, Phase II, Fuzhou, China, 350003, China
  • Websitehttps://www.cosunter.com

Leadership

  • Mr. Yan Ru HuDeputy General Manager · b. 1984

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue105.04M124.09M178.15M254.47M308.92M312.88M296.12M402.40M414.87M368.49M370.44M385.77M422.71M441.46M416.37M
Growth (%)-+18.14%+43.56%+42.84%+21.40%+1.28%-5.36%+35.89%+3.10%-11.18%+0.53%+4.14%+9.58%+4.43%-5.68%
Cost of Revenue15.24M19.29M26.37M36.87M38.77M41.17M38.58M66.17M94.71M124.92M140.19M162.62M186.54M202.19M156.88M
Gross Profit89.80M104.81M151.79M217.60M270.15M271.71M257.54M336.23M320.16M243.57M230.25M223.15M236.18M239.27M259.49M
Gross Margin85.49%84.46%85.20%85.51%87.45%86.84%86.97%83.55%77.17%66.10%62.16%57.85%55.87%54.20%62.32%
Operating Expense51.11M57.56M86.67M123.08M156.02M201.89M220.58M324.18M307.61M228.41M274.73M383.44M531.67M403.77M345.44M
Operating Income38.69M47.25M65.12M94.52M114.14M69.83M36.96M12.05M12.55M15.16M-44.48M-160.29M-295.49M-164.51M-85.95M
Operating Margin36.83%38.07%36.55%37.14%36.95%22.32%12.48%2.99%3.02%4.11%-12.01%-41.55%-69.90%-37.26%-20.64%
EBITDA39.35M52.39M69.09M100.56M116.75M74.73M35.98M24.08M35.51M36.54M-29.29M-166.66M-140.26M-30.19M-103.28M
EBITDA Margin37.46%42.22%38.78%39.52%37.79%23.89%12.15%5.98%8.56%9.92%-7.91%-43.20%-33.18%-6.84%-24.80%
Net Income33.82M43.16M57.26M83.77M103.49M66.41M33.57M16.48M10.74M14.82M-34.89M-127.40M-348.59M-156.30M-217.85M
Net Income Margin32.20%34.78%32.14%32.92%33.50%21.23%11.33%4.10%2.59%4.02%-9.42%-33.03%-82.46%-35.41%-52.32%
R&D-6.35M15.55M15.07M22.49M60.81M58.87M69.65M53.21M47.47M68.99M185.46M132.96M44.05M31.83M
R&D as % of Total Revenue-5.11%8.73%5.92%7.28%19.43%19.88%17.31%12.83%12.88%18.62%48.08%31.45%9.98%7.65%
Interest Expense391.08K40.90K52.25K74.90K23.64K46.49K56.61K1.23M7.55M9.05M9.24M10.73M35.03M35.60M32.85M
Interest Expense % of Total Revenue0.37%0.03%0.03%0.03%0.01%0.01%0.02%0.30%1.82%2.45%2.49%2.78%8.29%8.06%7.89%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets109.29M149.41M197.53M224.11M600.70M700.67M736.47M854.68M896.25M1.01B1.45B1.49B1.61B1.44B1.40B
Total Liabilities43.86M40.82M54.42M67.24M81.50M148.30M184.42M292.33M322.51M424.10M396.92M539.22M1.05B1.04B1.05B
Total Equity65.43M108.59M143.10M156.87M519.20M552.36M552.05M554.04M563.62M576.60M1.04B928.46M516.48M360.18M277.53M
Cash38.75M53.45M71.36M75.72M393.41M414.87M408.06M85.91M93.72M135.99M393.57M238.98M202.83M143.95M213.93M
Total Debt--200.00K--59.95M56.94M58.10M134.92M211.28M124.76M293.41M386.96M324.54M-
Net Debt-38.75M-53.45M-71.16M-75.72M-393.41M-414.87M-408.06M-27.81M41.20M75.29M-268.82M54.44M184.13M180.59M174.30M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow53.15M41.97M66.20M107.04M111.63M73.84M71.47M10.94M33.99M15.60M-17.76M-119.68M-174.60M20.71M-35.05M
Investing Cash Flow-19.86M-26.24M-24.61M-31.04M-336.93M152.67M9.73M-319.40M-73.48M-35.01M-174.38M-197.21M-207.41M-45.81M-
Financing Cash Flow-20.67M-1.04M-23.68M-71.63M262.74M24.95M-38.01M-13.70M47.30M61.68M445.58M162.53M349.71M-34.46M-
Capital Expenditure19.96M26.24M24.61M31.04M31.97M82.50M35.57M229.26M67.81M54.45M174.41M195.96M201.24M66.99M59.55M
Free Cash Flow33.19M15.74M41.59M76.00M79.66M-8.66M35.89M-218.32M-33.83M-38.86M-192.17M-315.64M-375.83M-46.28M-94.60M
Dividends Paid970.71K-22.75M70.01M35.00M35.00M35.45M15.23M7.37M8.84M9.17M10.35M17.40M17.42M15.36M
FCF to OCF62.44%37.49%62.83%71.00%71.36%-11.73%50.22%-1994.88%-99.52%-249.13%1081.76%263.74%215.26%-223.49%269.88%
Dividend Paid to FCF2.92%-54.70%92.13%43.94%-404.14%98.76%-6.98%-21.80%-22.75%-4.77%-3.28%-4.63%-37.64%-16.24%

Earnings

Report DateJul 14, 2015Oct 22, 2015Jan 18, 2016Apr 24, 2016Aug 16, 2016Oct 23, 2016Feb 28, 2017Apr 17, 2017Aug 14, 2017Oct 26, 2017Mar 20, 2018Apr 27, 2018Aug 24, 2018Oct 25, 2018Apr 1, 2019Aug 26, 2019Oct 25, 2019Feb 29, 2020Apr 23, 2020Aug 26, 2020Oct 27, 2020Apr 13, 2021Aug 26, 2021Oct 27, 2021Apr 22, 2022Jul 28, 2022Oct 25, 2022Apr 21, 2023Aug 29, 2023Oct 28, 2023May 13, 2024Aug 28, 2024Oct 25, 2024May 13, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------
EPS Actual0.180.210.150.200.090.130.050.140.050.020.030.09-0.060.010.050.030.02-0.020.010.070.03-0.00-0.13-0.02-0.09-0.11-0.28-0.35-0.59-0.24-0.96-0.13-0.22-0.54-0.24-0.28-0.67-0.16-0.27
Surprise---------------------------------------
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market---------After-hours--After-hours-----

Key Statistics & Ratios

Market Cap14.06B
Enterprise Value14.94B
Trailing P/E0.00
Forward P/E0.00
Price / Sales32.88
Price / Book69.88
EPS-1.38
Book Value1.32
Revenue (TTM)427.67M
Gross Profit (TTM)216.54M
EBITDA-60.55M
Profit Margin-51.28%
Operating Margin-31.46%
Return on Equity-82.74%
Return on Assets-6.63%
Shares Outstanding168.03M
Shares Float97.51M
Beta1.18
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20181×
0.10May 4, 2018
20171×
0.25Apr 28, 2017
20161×
0.25May 24, 2016

Stock Splits

  • Sep 16, 201520:10